Post by Pfizer Inc. on X
Pfizer Inc.@pfizer
XInsights from a global study show HCPs put disease control as a top priority while patients with relapsed/refractory multiple myeloma (RRMM) primarily focus on managing side effects and disease control. Read the analysis of treatment priorities.
30 likes0 repliesPosted Oct 23, 2025